TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | 3 | 12 | 21 | 3 | 8 | 8 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/23 18:02 | 3/14/23 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Edrick Alan I | MA | D | P.m | 79 | 2.64 | 0 | 30 | 17 | 202 | D | |||||||||||||||
6/16/20 18:00 | 6/12/20 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Edrick Alan I | MA | D | P | 53 | 2.63 | 0 | 20 | 42 | 68 | D | |||||||||||||||
9/19/07 20:16 | 9/19/07 | OSIS | Osi Systems Inc | CA | Tech | Semicn | Semiconductors & Related Devi | Edrick Alan I | CA | O | CFO,EVP | P | 53 | 21.37 | 9 | 3 | New | 3 | D | 36 | 18 | -17 | -25 | -11 | -15 | -2 | 1 | 2 | 3 | 12 | 21 | 3 | 8 |
8/18/04 15:44 | 8/16/04 | BIOI | Biosource International Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Edrick Alan I | CA | O | EVP,CFO | P | 19 | 6.20 | 0 | 3 | 120 | 6 | D | ||||||||||||||
8/10/04 19:17 | 8/10/04 | BIOI | Biosource International Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Edrick Alan I | CA | O | Exec VP, | P | 16 | 6.35 | 0 | 3 | New | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |